Literature DB >> 23746459

Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum.

Marc Cruts1, Ilse Gijselinck, Tim Van Langenhove, Julie van der Zee, Christine Van Broeckhoven.   

Abstract

An expanded G4C2 hexanucleotide repeat in the proximal regulatory region of C9orf72 is a frequent cause of neurodegenerative diseases in the frontotemporal lobar degeneration (FTLD) and motor neuron disease (MND) spectrum. Although primarily characterized by variably abundant pathological inclusions of TDP-43 protein, the lesion load was extended to TDP-43-negative, p62-positive neuronal and glial inclusions in extended regions of the central nervous system (CNS), particularly in cerebellum, where they may be characteristic of a C9orf72 repeat expansion. Disease mechanisms associated with repeat expansion disorders, including haploinsufficiency, RNA toxicity, and abnormal translation of expanded repeat sequences, are beginning to emerge. We review genetic, clinical, and pathological highlights and discuss current insights into the biology of this novel type of repeat expansion disease.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C9orf72; TDP43-proteinopathy; amyotrophic lateral sclerosis; frontotemporal lobar degeneration; neurodegeneration; repeat expansion diseases

Mesh:

Substances:

Year:  2013        PMID: 23746459     DOI: 10.1016/j.tins.2013.04.010

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  65 in total

1.  C9orf72 repeat expansions that cause frontotemporal dementia are detectable among patients with psychosis.

Authors:  Annie Watson; Mochtar Pribadi; Kodavali Chowdari; Sue Clifton; Bruce L Miller; Giovanni Coppola; Vishwajit Nimgaonkar
Journal:  Psychiatry Res       Date:  2015-12-08       Impact factor: 3.222

2.  C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.

Authors:  Antonino Cannas; Paolo Solla; Giuseppe Borghero; Gian Luca Floris; Adriano Chio; Marcello Mario Mascia; Nicola Modugno; Antonella Muroni; Gianni Orofino; Francesca Di Stefano; Andrea Calvo; Cristina Moglia; Gabriella Restagno; Mario Meloni; Rita Farris; Daniela Ciaccio; Roberta Puddu; Melisa Iris Vacca; Rosanna Melis; Maria Rita Murru; Stefania Tranquilli; Daniela Corongiu; Marcella Rolesu; Stefania Cuccu; Maria Giovanna Marrosu; Francesco Marrosu
Journal:  J Neurol       Date:  2015-08-15       Impact factor: 4.849

Review 3.  Dementia in 2013: frontotemporal lobar degeneration-building on breakthroughs.

Authors:  Julie van der Zee; Christine Van Broeckhoven
Journal:  Nat Rev Neurol       Date:  2014-01-07       Impact factor: 42.937

Review 4.  Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Nature       Date:  2013-09-05       Impact factor: 49.962

Review 5.  Amyotrophic lateral sclerosis: an update on recent genetic insights.

Authors:  Yohei Iguchi; Masahisa Katsuno; Kensuke Ikenaka; Shinsuke Ishigaki; Gen Sobue
Journal:  J Neurol       Date:  2013-10-02       Impact factor: 4.849

6.  Jump from pre-mutation to pathologic expansion in C9orf72.

Authors:  Zhengrui Xi; Marka van Blitterswijk; Ming Zhang; Philip McGoldrick; Jesse R McLean; Yana Yunusova; Erin Knock; Danielle Moreno; Christine Sato; Paul M McKeever; Raphael Schneider; Julia Keith; Nicolae Petrescu; Paul Fraser; Maria Carmela Tartaglia; Matthew C Baker; Neill R Graff-Radford; Kevin B Boylan; Dennis W Dickson; Ian R Mackenzie; Rosa Rademakers; Janice Robertson; Lorne Zinman; Ekaterina Rogaeva
Journal:  Am J Hum Genet       Date:  2015-05-21       Impact factor: 11.025

Review 7.  Neurodegenerative diseases: expanding the prion concept.

Authors:  Lary C Walker; Mathias Jucker
Journal:  Annu Rev Neurosci       Date:  2015-03-30       Impact factor: 12.449

Review 8.  The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.

Authors:  Stacey Li Hi Shing; Mary Clare McKenna; We Fong Siah; Rangariroyashe H Chipika; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-05       Impact factor: 3.978

9.  The Lysosomal Trafficking Transmembrane Protein 106B Is Linked to Cell Death.

Authors:  Hiroaki Suzuki; Masaaki Matsuoka
Journal:  J Biol Chem       Date:  2016-08-25       Impact factor: 5.157

Review 10.  Frontotemporal Dementia.

Authors:  Roger E Kelley; Ramy El-Khoury
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.